Today 15.00 'The Cost of Treating Tuberculosis' the first in a series of 3 webinars focused on topics related to health economics and TB, hosted by ERA4TB, the National Institute for Health and Care Excellence (NICE) and COMBINE. Register forms.biocom.de/index.php/68... @sedonasweeney.bsky.social

🌍 🏦 Tomorrow @sedonasweeney.bsky.social will give a webinar with @era4tb.bsky.social & @amr-accelerator.bsky.social on TB’s global cost burden to people and health systems, and how health economics can help direct priorities for developing new TB treatments Join 👇 amr-accelerator.eu/event/combin...

💊 On #WorldTBDay, we wanted to highlight just one example of our Centre’s work on tuberculosis A recent paper from @sedonasweeney.bsky.social found how the BPal multi-antibiotic regimen was the most cost-effective treatment for rifampicin-resistant #TB Read more 🔽 www.lshtm.ac.uk/research/cen...

Closing today… open to US scientists, just saying… Come join an interdisciplinary team looking #AMR dynamics from multiple angles!

Good morning to this man, and this man only #bbcqt

A bright light in a dark moment: The price of the critical TB drug bedaquiline has now dropped to $90 per adult treatment course for TB, a 54% reduction since just 2023. This is a huge win for @tbfighters.org and the TB activism community generally. www.stoptb.org/what-we-do/f... (1/2)...

Just received this photo from a friend of a warehouse in Kinshasa. These are tuberculosis medications--ALREADY PAID FOR--that aren't being distributed due to the Trump Administration's stop work order. TB treatment is being interrupted in SO many patients around the world. What does that mean? (1/2)

The deadline for this is Friday! do get in touch if you have any questions.

#Tuberculosis: We conducted the first within-trial cost-utility analysis of 6-month BPaL-based regimens (bedaquiline, pretomanid, and linezolid) for rifampin-resistant #TB. More about our findings below ⬇️ #IDSky #AidSky #MedSky

On Tuesday 11 Feb, join us for an amazing symposium, free and open to all. No registration required tinyurl.com/335xhj29

PhD opportunity @lshtm-tbmod.bsky.social modelling intersection of TB (world #1 infectious killer) & climate change. Do apply to be part of a great group doing impactful work! www.lshtm.ac.uk/study/fees-a... @lshtm.bsky.social @cmmid-lshtm.bsky.social @reinhouben.bsky.social @laragosce.bsky.social

What’s his beef against USAID in particu….oh. Wow.

USAID being unlawfully dismantled. DOGE member has closed HQ. New tranche of workers cut off email. Staff tell me, "It is frightening being inside USAID right now. Our checks and balances failed. Congress has abdicated its responsibilities.” And Sec. Rubio has abdicated his.

BPaL/M is cost saving based on our in-trial economic evaluation of TB-Practecal, supporting modelling studies. Great collaboration with Dr Sedona Sweeney @lshtm.bsky.social and @msfsci.bsky.social. www.thelancet.com/journals/lan... #TBsky #IDsky

Amazing timing that this paper has come out just as I return to work from maternity leave! Very proud of the work that went into this, and glad it is finally out. www.sciencedirect.com/science/arti...

🎉 Bringing you our new Bluesky account all the way from Windsor While we’re enjoying our retreat, why don’t you follow the new #GHECO account? It's the perfect place to get all the latest health economics news & updates in @lshtm.bsky.social